Submissions for variant NM_001267550.2(TTN):c.30444G>A (p.Ser10148=)

gnomAD frequency: 0.00003  dbSNP: rs367901929

Total submissions: 15

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	RCV000040106	SCV000063797	likely benign	not specified	2012-11-20	criteria provided, single submitter	clinical testing	Ser8904Ser in exon 105 of TTN: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. Ser8904Ser in exon 105 of TTN (allele freque ncy = n/a)
Labcorp Genetics (formerly Invitae), Labcorp	RCV000531925	SCV000642959	benign	Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J	2025-01-08	criteria provided, single submitter	clinical testing
Eurofins Ntd Llc (ga)	RCV000040106	SCV000703104	likely benign	not specified	2017-05-24	criteria provided, single submitter	clinical testing
GeneDx	RCV000040106	SCV000726535	likely benign	not specified	2018-01-05	criteria provided, single submitter	clinical testing	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Genome-Nilou Lab	RCV001839572	SCV002101863	benign	Autosomal recessive limb-girdle muscular dystrophy type 2J	2021-09-10	criteria provided, single submitter	clinical testing
Genome-Nilou Lab	RCV001839573	SCV002101865	benign	Myopathy, myofibrillar, 9, with early respiratory failure	2021-09-10	criteria provided, single submitter	clinical testing
Genome-Nilou Lab	RCV001839574	SCV002101866	benign	Early-onset myopathy with fatal cardiomyopathy	2021-09-10	criteria provided, single submitter	clinical testing
Genome-Nilou Lab	RCV001839571	SCV002101867	benign	Tibial muscular dystrophy	2021-09-10	criteria provided, single submitter	clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV000040106	SCV002547652	likely benign	not specified	2022-05-16	criteria provided, single submitter	clinical testing
CeGaT Center for Human Genetics Tuebingen	RCV001701582	SCV004698652	likely benign	not provided	2023-12-01	criteria provided, single submitter	clinical testing	TTN: BP4, BP7
Clinical Genetics, Academic Medical Center	RCV000040106	SCV001919189	benign	not specified		no assertion criteria provided	clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht	RCV001701582	SCV001928402	likely benign	not provided		no assertion criteria provided	clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+	RCV001701582	SCV001951934	likely benign	not provided		no assertion criteria provided	clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center	RCV001701582	SCV001970245	likely benign	not provided		no assertion criteria provided	clinical testing
PreventionGenetics, part of Exact Sciences	RCV004534884	SCV004753382	likely benign	TTN-related disorder	2019-04-08	no assertion criteria provided	clinical testing	This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).